ERP SELECTION INSIGHT AND BEST PRACTICES

Most ERP implementation problems start during software selection. The ten selection risks leaders should never ignore, from weak requirements to sales-led demos and hidden costs.

Choosing ERP in a validated environment is different. This 2026 buyer’s guide shows how to evaluate life sciences ERP through a GxP lens—Part 11 e‑signatures, audit trails, QA release, lot/expiry traceability, and LIMS/QMS/EDMS integrations. Get selection criteria, a weighted scorecard, and five scripted demos to run with your data so your shortlist is CSV‑ready before contracts.

Software selection becomes risky when decisions hinge on demos instead of evidence. This guide shows how to structure selection with clear criteria, weighted scorecards, scripted day-in-the-life demos, integration and data checks, and TCO analysis. Built from more than two decades of running selections across manufacturing, distribution, and life sciences, it’s a vendor-neutral playbook for confident and defensible decisions that hold up on go-live day.

An industry label does not automatically make an ERP system the right choice. Some industry-specific ERP platforms provide an excellent operational fit. Others may address a narrow set of requirements while creating limitations in finance, reporting, integrations, scalability, or long-term support.

The Drug Supply Chain Security Act (DSCSA) is pushing the industry toward an interoperable, electronic way to identify and trace certain prescription drugs at the package level as they move through the supply chain.